Kintara Therapeutics Inc. Stock Forecast
Kintara Therapeutics Inc. stock price ended at $0.151 on Friday, after losing 3.75%.
(Updated on May 03, 2024)
The Kintara Therapeutics Inc. stock price fell by -3.75% on the last day (Friday, 3rd May 2024) from $0.157 to $0.151. During the last trading day the stock fluctuated 8.34% from a day low at $0.150 to a day high of $0.162. The price has been going up and down for this period, and there has been a 24.63% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -644 thousand shares and in total, 3 million shares were bought and sold for approximately $420.24 thousand.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 28.15% during the next 3 months and, with a 90% probability hold a price between $0.137 and $0.228 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
KTRA Signals & Forecast
The Kintara Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.154. On a fall, the stock will find some support from the long-term average at approximately $0.120. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, April 29, 2024, and so far it has fallen -6.95%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for Kintara Therapeutics Inc. stock
Kintara Therapeutics Inc. finds support from accumulated volume at $0.149 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0125 between high and low, or 8.34%. For the last week the stock has had daily average volatility of 11.27%.
Our recommended stop-loss: $0.143 (-5.68%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 4 days ago.)
Trading Expectations (KTRA) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Kintara Therapeutics Inc. to open at $0.155, and during the day (based on 14 day Average True Range), to move between $0.132 and $0.171, which gives a possible trading interval of +/-$0.0197 (+/-13.02%) up or down from last closing price. If Kintara Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 26.03% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.149 (1.65%) than the resistance at $0.158 (4.43%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Kintara Therapeutics Inc. will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.250. We will update the financials statements for Kintara Therapeutics Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.81% in the first trading day after earnings release.
Is Kintara Therapeutics Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Kintara Therapeutics Inc. stock to perform well in the short-term.
Current score: 1.501 Buy Candidate Unchanged
Predicted Opening Price for Kintara Therapeutics Inc. of Monday, May 6, 2024
Fair opening price May 6, 2024 | Current price |
---|---|
$0.155 ( 2.14%) | $0.151 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for KTRA
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0.167 | 10.40 % | |
R2 | 0.162 | 7.24 % | ||
R1 | 0.159 | 5.29 % | ||
Current price: | 0.151 | |||
Support | S1 | 0.150 | -1.02 % | |
S2 | 0.147 | -2.97 % | ||
S3 | 0.142 | -6.12 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0.164 | 8.39 % | |
R2 | 0.163 | 7.47 % | ||
R1 | 0.158 | 4.43 % | ||
Current price | 0.151 | |||
Support | S1 | 0.149 | -1.65% | |
S2 | 0.144 | -5.02% | ||
S3 | 0.122 | -19.30% |
FAQ
Click here for our free guide on how to buy Kintara Therapeutics Inc. Stock.